封面
市場調查報告書
商品編碼
2032662

熱原檢測市場報告:按產品、檢測類型、應用和地區分類(2026-2034 年)

Pyrogen Testing Market Report by Product (Instruments, Kits and Reagents, Services), Test Type (In-vitro Tests, LAL Tests, Rabbit Tests, and Others), Application (Pharmaceutical and Biologics, Medical Devices, and Others), and Region 2026-2034

出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

2025年,全球熱原檢測市場規模達16億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到34億美元,2026年至2034年的複合年成長率(CAGR)為8.36%。推動該市場成長的因素包括:全球製藥和生技產業的擴張、心臟病、癌症和糖尿病等慢性疾病盛行率的上升,以及用於新療法上市和研發活動的資金增加。

熱原檢測市場分析:

  • 市場主要促進因素:慢性疾病發生率上升(需要治療性介入)以及藥品和醫療設備產量增加是推動該市場成長的主要因素。此外,政府強制要求在醫療產品生產中進行熱原檢測的措施也為熱原檢測市場創造了有利條件。
  • 市場主要趨勢:目前,受倫理考量和監管政策的驅動,非動物實驗方法正日益受到青睞。此外,自動化和先進數據分析技術的整合也正在推動測試效率的提升。
  • 區域趨勢:北美是關鍵區域之一,這得益於其先進的醫療保健基礎設施和嚴格的FDA監管。此外,在亞太地區,受中國和印度等國製藥業擴張和醫療保健支出成長的推動,熱原檢測市場的收入也在成長。
  • 競爭格局:熱原檢測產業的主要市場參與者包括 Charles River Laboratories International Inc.、Ellab A/S、Fujifilm Wako Pure Chemical Corporation(Fujifilm Holdings Corporation)、Lonza Group AG、Merck KGaA、Microcoat Biotechnologie GmbH、Nelson Laboratories(Sotera Health)、Northcrocoat Biotechnologie GmbH、Nelson Laboratories(Sotera Health)、Sot Associates)、Sanc​​ Sciences Inc. Inc.、Toxikon Corporation、Wuxi Apptec. 等。
  • 挑戰與機會:市場調查顯示,熱原檢測領域面臨許多挑戰,例如先進熱原檢測方法高成本,以及需要專業人員進行這些檢測。然而,這些挑戰也為市場參與者提供了機遇,他們可以創新開發更具成本效益的解決方案和培訓項目,以彌合技能差距。

熱原檢測市場的發展趨勢:

監理合規和安全標準

熱原檢測市場的成長主要得益於美國食品藥物管理局(FDA) 和歐洲藥品管理局 (EMA) 等衛生監管機構所推出的嚴格法規結構。美國醫療設備促進協會 (AAMI) 發布的 ST72;2002/R2010《細菌內毒素-調查方法、常規監測及批次檢測替代方案 (AAMI ST72)》文件說明了凝膠凝固法、光強度和動態檢測方法的基本原理,並建議對相關組件和成品進行熱原和內毒素檢測。這些法規要求對藥品、醫療設備和生物製藥進行嚴格的安全檢測,以確保其不含可能引起發燒並對患者構成嚴重風險的熱原。因此,製造商正在將熱原檢測納入其生產流程。

製藥和生物技術產業的進步

製藥和生物技術產業的成長,以及生物製藥產量的不斷增加,也改善了熱原檢測市場的前景。生物來源的生物製藥容易受到熱原污染。根據IMARC Group的數據顯示,2023年全球生物製藥市場規模達3,496億美元。展望未來,預計到2032年,熱原檢測市場規模將達到6,995億美元,2024年至2032年的複合年成長率(CAGR)為7.8%。隨著這些產業的擴張,對先進、可靠、快速的熱原檢測方法的需求也不斷成長。此外,這種需求正在推動檢測技術的創新,例如重組因子C(rFC)檢測,它是傳統鱟血檢測的合成替代方案。

醫療基礎建設

新興國家醫療基礎設施的發展以及對符合國際安全標準(包括無熱原認證)的醫療產品日益成長的需求,正在加速熱原檢測的需求成長。這種成長擴大了熱原檢測的地理市場,並鼓勵當地製造商採用先進的檢測技術進入全球市場。此外,醫療體系的發展和醫療支出的成長也推動了先進熱原檢測流程的採用和整合。同時,政府部門也在增加對醫療產業的投資,以促進公眾健康。例如,美國疾病管制與預防中心(CDC)已津貼32億美元,用於幫助美國各州、地方政府和地區加強公共衛生人員和基礎設施建設。這32億美元中包括根據《美國救援計畫法案》撥付的30億美元,各轄區將利用這筆資金招募、留住和培訓負責人,包括流行病學家、接觸者追蹤員、實驗室技術人員、社區衛生工作者和數據分析師——這些都是至關重要的公共衛生一線工作者。這項資金還包括1.4億美元,作為每個轄區加強和振興公共衛生基礎設施的新預算。

目錄

第1章:序言

第2章:調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章:引言

第5章:全球熱原檢測市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔:依產品分類

  • 裝置
  • 試劑盒和試劑
  • 服務

第7章 市場區隔:依測試類型分類

  • 體外試驗
  • LAL檢查
  • 兔子試驗
  • 其他

第8章 市場區隔:依應用領域分類

  • 藥品和生物製藥
  • 醫療器材
  • 其他

第9章 市場區隔:依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章:價值鏈分析

第12章:波特五力分析

第13章:價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Charles River Laboratories International Inc.
    • Ellab A/S
    • Fujifilm Wako Pure Chemical Corporation(Fujifilm Holdings Corporation)
    • Lonza Group AG
    • Merck KGaA
    • Microcoat Biotechnologie GmbH
    • Nelson Laboratories LLC(Sotera Health)
    • North American Science Associates Inc.
    • Pacific Biolabs Inc.
    • Sanquin
    • Thermo Fisher Scientific Inc
    • Toxikon Corporation
    • Wuxi Apptec
Product Code: SR112026A4601

The global pyrogen testing market size reached USD 1.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.4 Billion by 2034, exhibiting a growth rate (CAGR) of 8.36% during 2026-2034. The market is propelled by the expanding pharmaceutical and biotechnology industries around the world, the increasing prevalence of chronic ailments such as heart diseases, cancer, and diabetes, and the launch of the new therapeutics and rising funding of research and development (R&D) activities.

PYROGEN TESTING MARKET ANALYSIS :

  • Major Market Drivers: The market is driven by the rising incidence of chronic diseases that require therapeutic intervention and the increasing pharmaceutical and medical device manufacturing. Moreover, the implementation of government initiatives requiring pyrogen testing in the manufacturing of healthcare products also creating a favorable pyrogen testing market overview.
  • Key Market Trends: At present, there is a growing trend toward adopting animal-free testing methods, driven by ethical considerations and regulatory policies. Additionally, the market is seeing a shift toward automation and integration of advanced data analytics to enhance testing efficiency.
  • Geographical Trends: North America is among the leading regions due to its advanced healthcare infrastructure and stringent FDA regulations. Moreover, Asia Pacific is also experiencing growing pyrogen testing market revenue, fueled by expanding pharmaceutical manufacturing and increasing healthcare spending in countries like China and India.
  • Competitive Landscape: Some of the major market players in the pyrogen testing industry include Charles River Laboratories International Inc., Ellab A/S, Fujifilm Wako Pure Chemical Corporation (Fujifilm Holdings Corporation), Lonza Group AG, Merck KGaA, Microcoat Biotechnologie GmbH, Nelson Laboratories LLC (Sotera Health), North American Science Associates Inc., Pacific Biolabs Inc., Sanquin, Thermo Fisher Scientific Inc, Toxikon Corporation Wuxi Apptec., among many others.
  • Challenges and Opportunities: The pyrogen testing market research showed challenges such as high costs associated with advanced pyrogen testing methods and the need for skilled personnel to conduct advanced tests. However, these challenges present opportunities for market players to innovate cost-effective solutions and training programs to fill the skills gap.

PYROGEN TESTING MARKET TRENDS:

Regulatory compliance and safety standards

The pyrogen testing market growth is significantly driven by the implementation of stringent regulatory frameworks by health authorities such as the FOOD and DRUGS ADMINISTRATION in the United States and the EUROPEAN MEDICINE AGENCY in Europe. The Association for the Advancement of Medical Instrumentation (AAMI) ST72:2002/R2010, Bacterial Endotoxins-Test Methodologies, Routine Monitoring, and Alternatives to Batch Testing (AAMI ST72) are documents that describe the fundamental principles of the gel clot, photometric, and kinetic test methods, and recommend that appropriate components and finished products be tested for the presence of pyrogens and endotoxins. These regulations require rigorous safety testing of pharmaceuticals, medical devices, and biological products to ensure they are free of pyrogens, which can induce fever and pose severe risks to patients. As a result, manufacturers are incorporating pyrogen testing in their production processes.

Advancements in pharmaceuticals and biotechnology industries

The growth of the pharmaceutical and biotechnology sectors and the increasing biologics production is also creating a favorable pyrogen testing market outlook. Biologics, derived from living organisms are susceptible to contamination by pyrogens. According to IMARC GROUP, the global biologics market size reached US$ 349.6 Billion in 2023. Looking forward, the pyrogen testing market value is expected to reach US$ 699.5 Billion by 2032, exhibiting a growth rate (CAGR) of 7.8% during 2024-2032. As these industries expand, the requirement for sophisticated, reliable, and rapid pyrogen testing methods is also increasing. Moreover, this demand is leading to innovations in testing technologies, such as recombinant factor C (rFC) assays, which offer a synthetic alternative to traditional horseshoe crab blood-derived tests.

Developing healthcare infrastructure

The developing healthcare infrastructure in emerging economies and the increasing need for medical products that meet international safety standards, including pyrogen-free certifications is escalating the pyrogen testing demand. This expansion broadens the geographic market for pyrogen testing and compels local manufacturers to adopt advanced testing technologies to participate in global markets. Moreover, the development of healthcare systems and the increased healthcare spending is increasing the adoption and integration of advanced pyrogen testing processes. Besides, government authorities are also investing in the healthcare industry to promote public health. For instance, CENTER for DISEASE CONTROL and PREVENTION has awarded $3.2 billion to help state, local, and territorial jurisdictions across the United States strengthen their public health workforce and infrastructure. The $3.2 billion includes $3 billion from the AMERICAN RESCUE PLAN ACT for jurisdictions to recruit, retain, and train their workforce, including critical frontline public health workers such as epidemiologists, contact tracers, laboratory scientists, community health workers, and data analysts. The funding also includes $140 million from a new appropriation for jurisdictions to strengthen and revitalize their public health infrastructure.

PYROGEN TESTING MARKET SEGMENTATION :

Breakup by Product:

  • Instruments
  • Kits and Reagents
  • Services

Kits and reagents accounts for the majority of the market share

Kits and reagents are user-friendly allowing for quick setup and execution of tests by laboratory personnel without the need for extensive specialized training. This convenience leads to faster turnaround times in testing. Besides, pre-packaged kits and reagents are more cost-effective than in-house testing methods. The costs associated with R&D, validation, and quality control of self-made tests can be prohibitively high, especially for smaller companies. Moreover, companies are acquiring and merging with other companies and launching new advanced products to expand their pyrogen testing market share. For instance, in March 2021, PromegaCorp. launched XpressAmp Direct amplification reagent.

Breakup by Test Type:

  • In-vitro Tests
  • LAL Tests
  • Rabbit Tests
  • Others

LAL tests hold the largest share of the industry

LAL tests are highly sensitive to bacterial endotoxins, capable of detecting them at very low levels. The sensitivity of these tests is crucial for ensuring the safety of pharmaceuticals and medical devices. Moreover, due to its proven reliability, the LAL test has become the standard method for endotoxin testing and is widely trusted by regulatory authorities and manufacturers. Besides, the LAL test is recognized and recommended by major regulatory bodies, including the U.S. Food and Drug Administration (FDA) and the European Pharmacopoeia. For more than 30 years, FDA has accepted the use of a Limulus Amoebocyte Lysate (LAL) test for endotoxins in lieu of the rabbit pyrogens test.

Breakup by Application:

  • Pharmaceutical and Biologics
  • Medical Devices
  • Others

Pharmaceutical and biologics represents the leading market segment

The biologics sector is growing rapidly, driven by advancements in biotechnology and an increasing focus on personalized medicine. This expansion contributes to a greater demand for pyrogen testing as more biologics enter research pipelines and commercial production. Moreover, pharmaceutical and biotechnology companies are investing heavily in research and development to create new drugs and biological products which necessitate rigorous safety testing, including pyrogen testing, to ensure that these innovations are safe for human use. For instance, California-based Amgen Inc. invests heavily in its research and development activities and its expenditure for research and development was US$ 4.8 Billion, US$ 4.2 Billion, and US$ 4.1 Billion, for 2021, 2020, and 2019, respectively, as per its 2021 company annual report. These factors are expanding the use of these testing in pharmaceutical and biologics thus creating a positive pyrogen testing market forecast.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest pyrogen testing market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for pyrogen testing.

North America boasts an advanced healthcare infrastructure with a strong emphasis on regulatory compliance and patient safety. This infrastructure supports and demands high standards for medical products, influencing the need for pyrogen testing to ensure the safety of pharmaceuticals and medical devices. Besides, the healthcare expenditure in North America is among the highest in the world, with significant spending allocated to health innovation, including safety testing. According to the CENTERS FOR MEDICARE & MEDICAID SERVICES, the United States healthcare spending grew 4 pending grew 4.1% to reach $4.5 Trillion in 2022, faster than the increase of 3.2% in 2021. Besides, retail prescription drug spending increased 8.4% to $405.9 Billion in 2022, a faster rate than in 2021 when spending increased by 6.8%. This financial capability is escalating the need for pyrogen testing, across the healthcare and pharmaceutical sectors.

COMPETITIVE LANDSCAPE:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the pyrogen testing industry include Charles River Laboratories International Inc., Ellab A/S, Fujifilm Wako Pure Chemical Corporation (Fujifilm Holdings Corporation), Lonza Group AG, Merck KGaA, Microcoat Biotechnologie GmbH, Nelson Laboratories LLC (Sotera Health), North American Science Associates Inc., Pacific Biolabs Inc., Sanquin Reagents BV, Thermo Fisher Scientific Inc, Toxikon Corporation and Wuxi Apptec. ()
  • The pyrogen testing market research report shows that leading companies are continually investing in research and development to improve existing products and create new, more efficient, and sensitive pyrogen testing methods. This includes the development of rapid tests and alternative methods like the monocyte activation test (MAT) and recombinant factor C (rFC) assay. Moreover, companies are increasingly focusing on expanding their presence in high-growth regions such as Asia-Pacific and Latin America as these regions offer significant opportunities due to their rapidly expanding pharmaceutical and medical device manufacturing sectors. According to IMARC Group, the India pharmaceutical market size reached US$ 54.6 Billion in 2023. Looking forward, it is expected to reach US$ 163.1 Billion by 2032, exhibiting a growth rate (CAGR) of 12.3% during 2024-2032. These values will continue to impact the pyrogen testing market statistics in the coming years.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global pyrogen testing market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global pyrogen testing market?
  • What is the impact of each driver, restraint, and opportunity on the global pyrogen testing market?
  • What are the key regional markets?
  • Which countries represent the most attractive pyrogen testing market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the pyrogen testing market?
  • What is the breakup of the market based on the test type?
  • Which is the most attractive test type in the pyrogen testing market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the pyrogen testing market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global pyrogen testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pyrogen Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Kits and Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 In-vitro Tests
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 LAL Tests
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Rabbit Tests
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Pharmaceutical and Biologics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Medical Devices
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Charles River Laboratories International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Ellab A/S
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Fujifilm Wako Pure Chemical Corporation (Fujifilm Holdings Corporation)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Lonza Group AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Merck KGaA
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Microcoat Biotechnologie GmbH
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Nelson Laboratories LLC (Sotera Health)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 North American Science Associates Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Pacific Biolabs Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Sanquin
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Thermo Fisher Scientific Inc
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Toxikon Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Wuxi Apptec
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials

List of Figures

  • Figure 1: Global: Pyrogen Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Pyrogen Testing Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Pyrogen Testing Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Pyrogen Testing Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Pyrogen Testing Market: Breakup by Test Type (in %), 2025
  • Figure 6: Global: Pyrogen Testing Market: Breakup by Application (in %), 2025
  • Figure 7: Global: Pyrogen Testing Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Pyrogen Testing (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Pyrogen Testing (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Pyrogen Testing (Kits and Reagents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Pyrogen Testing (Kits and Reagents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Pyrogen Testing (Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Pyrogen Testing (Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Pyrogen Testing (In-vitro Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Pyrogen Testing (In-vitro Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Pyrogen Testing (LAL Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Pyrogen Testing (LAL Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Pyrogen Testing (Rabbit Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Pyrogen Testing (Rabbit Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Pyrogen Testing (Other Test Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Pyrogen Testing (Other Test Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Pyrogen Testing (Pharmaceutical and Biologics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Pyrogen Testing (Pharmaceutical and Biologics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Pyrogen Testing (Medical Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Pyrogen Testing (Medical Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Pyrogen Testing (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Pyrogen Testing (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: North America: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: North America: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: United States: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: United States: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Canada: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Canada: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Asia-Pacific: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Asia-Pacific: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: China: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: China: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Japan: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Japan: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: India: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: India: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: South Korea: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: South Korea: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Australia: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Australia: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Indonesia: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Indonesia: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Others: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Others: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Europe: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Europe: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Germany: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Germany: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: France: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: France: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: United Kingdom: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: United Kingdom: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Italy: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Italy: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Spain: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Spain: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Russia: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Russia: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Others: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Others: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Latin America: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Latin America: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Brazil: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Brazil: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Mexico: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Mexico: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Others: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Others: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Middle East and Africa: Pyrogen Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Middle East and Africa: Pyrogen Testing Market: Breakup by Country (in %), 2025
  • Figure 76: Middle East and Africa: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Global: Pyrogen Testing Industry: SWOT Analysis
  • Figure 78: Global: Pyrogen Testing Industry: Value Chain Analysis
  • Figure 79: Global: Pyrogen Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pyrogen Testing Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Pyrogen Testing Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Pyrogen Testing Market Forecast: Breakup by Test Type (in Million USD), 2026-2034
  • Table 4: Global: Pyrogen Testing Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Pyrogen Testing Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Pyrogen Testing Market: Competitive Structure
  • Table 7: Global: Pyrogen Testing Market: Key Players